BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 27229712)

  • 1. Altered heme-mediated modulation of dendritic cell function in sickle cell alloimmunization.
    Godefroy E; Liu Y; Shi P; Mitchell WB; Cohen D; Chou ST; Manwani D; Yazdanbakhsh K
    Haematologica; 2016 Sep; 101(9):1028-38. PubMed ID: 27229712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemin controls T cell polarization in sickle cell alloimmunization.
    Zhong H; Bao W; Friedman D; Yazdanbakhsh K
    J Immunol; 2014 Jul; 193(1):102-10. PubMed ID: 24879794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of sickle cell alloimmunization.
    Yazdanbakhsh K
    Transfus Clin Biol; 2015 Aug; 22(3):178-81. PubMed ID: 26056038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemolysis inhibits humoral B-cell responses and modulates alloimmunization risk in patients with sickle cell disease.
    Pal M; Bao W; Wang R; Liu Y; An X; Mitchell WB; Lobo CA; Minniti C; Shi PA; Manwani D; Yazdanbakhsh K; Zhong H
    Blood; 2021 Jan; 137(2):269-280. PubMed ID: 33152749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoregulatory networks in sickle cell alloimmunization.
    Yazdanbakhsh K
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):457-461. PubMed ID: 27913516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune Regulation of sickle Cell Alloimmunization.
    Yazdanbakhsh K; Shaz BH; Hillyer CD
    ISBT Sci Ser; 2017 Feb; 12(1):248-253. PubMed ID: 28261322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Red blood cell alloimmunization is influenced by recipient inflammatory state at time of transfusion in patients with sickle cell disease.
    Fasano RM; Booth GS; Miles M; Du L; Koyama T; Meier ER; Luban NL
    Br J Haematol; 2015 Jan; 168(2):291-300. PubMed ID: 25256676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunophenotypic parameters and RBC alloimmunization in children with sickle cell disease on chronic transfusion.
    Nickel RS; Horan JT; Fasano RM; Meyer E; Josephson CD; Winkler AM; Yee ME; Kean LS; Hendrickson JE
    Am J Hematol; 2015 Dec; 90(12):1135-41. PubMed ID: 26361243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of red blood cell alloimmunization on sickle cell disease mortality: a case series.
    Nickel RS; Hendrickson JE; Fasano RM; Meyer EK; Winkler AM; Yee MM; Lane PA; Jones YA; Pashankar FD; New T; Josephson CD; Stowell SR
    Transfusion; 2016 Jan; 56(1):107-14. PubMed ID: 26509333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood.
    Vichinsky EP; Earles A; Johnson RA; Hoag MS; Williams A; Lubin B
    N Engl J Med; 1990 Jun; 322(23):1617-21. PubMed ID: 2342522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory B-cell compartment in transfused alloimmunized and non-alloimmunized patients with sickle cell disease.
    Bao W; Zhong H; Manwani D; Vasovic L; Uehlinger J; Lee MT; Sheth S; Shi P; Yazdanbakhsh K
    Am J Hematol; 2013 Sep; 88(9):736-40. PubMed ID: 23720018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for alloimmunization in patients with sickle cell anemia.
    Pinto PC; Braga JA; Santos AM
    Rev Assoc Med Bras (1992); 2011; 57(6):668-73. PubMed ID: 22249547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease.
    Rosse WF; Gallagher D; Kinney TR; Castro O; Dosik H; Moohr J; Wang W; Levy PS
    Blood; 1990 Oct; 76(7):1431-7. PubMed ID: 2207318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for alloimmunization by patients with sickle cell disease.
    Murao M; Viana MB
    Braz J Med Biol Res; 2005 May; 38(5):675-82. PubMed ID: 15917948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TIGIT-positive circulating follicular helper T cells display robust B-cell help functions: potential role in sickle cell alloimmunization.
    Godefroy E; Zhong H; Pham P; Friedman D; Yazdanbakhsh K
    Haematologica; 2015 Nov; 100(11):1415-25. PubMed ID: 26250578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Red blood cell alloimmunization is associated with lower expression of FcγR1 on monocyte subsets in patients with sickle cell disease.
    Balbuena-Merle R; Curtis SA; Devine L; Gibb DR; Karafin MS; Luckey CJ; Tormey CA; Siddon AJ; Roberts JD; Hendrickson JE
    Transfusion; 2019 Oct; 59(10):3219-3227. PubMed ID: 31355970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Saucerneol D inhibits dendritic cell activation by inducing heme oxygenase-1, but not by directly inhibiting toll-like receptor 4 signaling.
    Ryu HS; Lee HK; Kim JS; Kim YG; Pyo M; Yun J; Hwang BY; Hong JT; Kim Y; Han SB
    J Ethnopharmacol; 2015 May; 166():92-101. PubMed ID: 25792017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alloimmunization in sickle cell disease: changing antibody specificities and association with chronic pain and decreased survival.
    Telen MJ; Afenyi-Annan A; Garrett ME; Combs MR; Orringer EP; Ashley-Koch AE
    Transfusion; 2015 Jun; 55(6 Pt 2):1378-87. PubMed ID: 25444611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FcγR2B B2.4 haplotype predicts increased risk of red blood cell alloimmunization in sickle cell disease patients.
    Costa Neto A; Santos F; Ribeiro I; Oliveira V; Dezan M; Kashima S; Covas D; Pereira A; Fonseca G; Moreira F; Krieger J; Gualandro S; Rocha V; Mendrone A; Dinardo CL
    Transfusion; 2020 Jul; 60(7):1573-1578. PubMed ID: 32681817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic differences of CD4(+) T cells in response to red blood cell immunization in transfused sickle cell disease patients.
    Vingert B; Tamagne M; Habibi A; Pakdaman S; Ripa J; Elayeb R; Galacteros F; Bierling P; Ansart-Pirenne H; Bartolucci P; Noizat-Pirenne F
    Eur J Immunol; 2015 Jun; 45(6):1868-79. PubMed ID: 25763868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.